James Mitchell Crow

HPV: The global burden

Human papillomavirus (HPV) has become synonymous with cervical cancer, but its actual footprint is much bigger, by James Mitchell Crow.

Therapeutics: Silencing psoriasis

The latest drugs hold fantastic promise for people with severe psoriasis. But where are the treatment options for the far larger number with less serious cases?

Obesity: Insensitive issue

It is becoming clear that links between taste preferences and obesity go beyond simply having a sweet tooth.

Biomedicine: Move over, morphine.

The dearth of treatment options for chronic pain has led to widespread over-prescription of strong opioids. But some innovative thinking is building a promising pipeline.

Insomnia: Chasing the dream

A combination of drugs and cognitive behavioural therapy may finally put an end to the misery of sleepless nights.

Advocacy: Strong foundations

Most rare diseases lack even one approved treatment. Regulators have tried to encourage drug development, but advocacy groups are having to fight to get the research done.

Why New Zealand is an attractive destination for scientists

The nation’s fertile research landscape, combined with a sustained funding drive, makes it a rewarding place to work.The nation’s fertile research landscape, combined with a sustained funding drive, makes it a rewarding place to work.

Graphene towers promise 'flexi-electronics'

The 3D ‘monoliths’ — grown between forming ice crystals — add elasticity to the super-strength and conductivity of graphene sheets.

Boron finally gets a triple bond

Compound could be useful in organic electronic materials.

Australian research grants escape government cutbacks

But universities face cuts to overheads support.